Promising Injectable Laminitis Treatment Moves Forward
More than 40 horses with an acute or active chronic case of laminitis received treatment with Laminil this spring.
The reaction from owners and veterinarians of those horses was very positive across the board in describing how the horses responded.
Several owners and vets sent us video, and all of it is posted at laminil.us.
Many vets stated they wanted to continue receiving shipments of the drug to treat future cases.
At the same time, we experienced a lot of frustration over not being able to meet demand. In the days following our announcement that we needed laminitic horses for clinical testing, we were flooded with calls from owners and vets of laminitic horses around the world and simply couldn’t manage to serve that kind of volume at this stage. In one day, we received 97 calls.
When laminitis contributed to Kentucky Derby winner Barbaro’s death at the University of Pennsylvania’s New Bolton Center in 2007, the dreaded disease – an often-fatal complication of catastrophic limb injury – commanded enormous public attention. So did the fundraising efforts to cure this age-old veterinary problem.
Six years later, clinicians and researchers say, the veterinary profession is gaining ground in the battle, thanks to research and improvements in areas from digital radiography to glue-on horseshoes to cryotherapy, also known as cold therapy.
Some of that promising research is taking place at the New Bolton Center, which treated the two horses whose highly publicized bouts with the painful hoof disease in recent years have had very different outcomes: Barbaro, who was euthanized after developing laminitis secondary to his breakdown, and Haskell winner Paynter, who recovered from colitis-related laminitis last year and is back in training.